Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
4.190
-0.220 (-4.99%)
Feb 21, 2025, 4:00 PM EST - Market closed
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $269.24 million as of February 21, 2025. Its market cap has increased by 169.24% in one year.
Market Cap
269.24M
Enterprise Value
227.94M
1-Year Change
169.24%
Ranking
Category
Stock Price
$4.19
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has decreased from $290.80M to $269.24M, a decrease of -7.41%. That is a compound annual growth rate of -0.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 269.20M | -21.70% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |